Validated patient-reported outcome measurements for psoriasis may not reflect patients' current preferences - 12/04/19
Funding sources: None. |
|
Disclosure: Dr Cohen is a consultant for Ferndale Laboratories, Medimetriks, Erchonia, Cutanea, Ferrer, SkinFix, Celegene, and FIDE (FIDE receives industry sponsorship from AbbVie, Almirall, Bristol Myers, Celgene, Dermavant, Dermira, Janssen, Kyowa Hakko Kirin, LEO, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sun Pharma, and UCB); he owns stock or has stock options in Dermira, Medimetriks and Brickell Biotech; and he is on the board of directors of Dermira. Dr Ogbechie-Godec, Ms Azarchi, Ms Lee, Dr Neimann, and Dr Nagler have no conflicts of interest to disclose. |
Vol 80 - N° 5
P. 1445 - mai 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?